| ADHD comorbidities: Handbook for ADHD complications in children and adults TE Brown American Psychiatric Pub, 2009 | 198 | 2009 |
| Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti-reward systems MS Gold, K Blum, M Febo, D Baron, EJ Modestino, I Elman, ... Front Biosci (Schol Ed) 10 (2), 309-325, 2018 | 124 | 2018 |
| Genetic addiction risk score (GARS)™, a predictor of vulnerability to opioid dependence K Blum, ALC Chen, PK Thanos, M Febo, Z Demetrovics, K Dushaj, ... Front Biosci (Elite Ed) 10 (1), 175-196, 2018 | 74 | 2018 |
| Hoehn and Yahr staging of Parkinson’s disease in relation to neuropsychological measures EJ Modestino, A Reinhofer, K Blum, C Amenechi, P O’Toole Front Biosci (Landmark Ed) 23 (7), 1370-1379, 2018 | 70 | 2018 |
| A retrospective survey of childhood ADHD symptomatology among adult narcoleptics EJ Modestino, J Winchester Journal of attention disorders 17 (7), 574-582, 2013 | 69 | 2013 |
| Reward deficiency syndrome (RDS) surprisingly is evolutionary and found everywhere: is it “blowin’in the wind”? K Blum, T McLaughlin, A Bowirrat, EJ Modestino, D Baron, LL Gomez, ... Journal of personalized medicine 12 (2), 321, 2022 | 60 | 2022 |
| Understanding the scientific basis of post-traumatic stress disorder (PTSD): precision behavioral management overrides stigmatization K Blum, MC Gondré-Lewis, EJ Modestino, L Lott, D Baron, D Siwicki, ... Molecular neurobiology 56 (11), 7836-7850, 2019 | 60 | 2019 |
| The food and drug addiction epidemic: targeting dopamine homeostasis K Blum, PK Thanos, GJ Wang, M Febo, Z Demetrovics, EJ Modestino, ... Current pharmaceutical design 23 (39), 6050-6061, 2017 | 58 | 2017 |
| Hypodopaminergia and “Precision Behavioral Management”(PBM): it is a generational family affair L Fried, EJ Modestino, D Siwicki, L Lott, PK Thanos, D Baron, ... Current Pharmaceutical Biotechnology 21 (6), 528-541, 2020 | 56 | 2020 |
| Alice in Wonderland Syndrome: A real life version of Lewis Carroll’s novel P O'Toole, EJ Modestino Brain and Development 39 (6), 470-474, 2017 | 54 | 2017 |
| In search of reward deficiency syndrome (RDS)-free controls: the “holy grail” in genetic addiction risk testing K Blum, D Baron, L Lott, JV Ponce, D Siwicki, B Boyett, B Steinberg, ... Current psychopharmacology 9 (1), 7-21, 2020 | 45 | 2020 |
| High Genetic Addiction Risk Score (GARS) in chronically prescribed severe chronic opioid probands attending multi-pain clinics: An open clinical pilot trial M Moran, K Blum, JV Ponce, L Lott, MC Gondré–Lewis, S Badgaiyan, ... Molecular Neurobiology 58 (7), 3335-3346, 2021 | 44 | 2021 |
| Our evolved unique pleasure circuit makes humans different from apes: Reconsideration of data derived from animal studies K Blum, M Gondré-Lewis, B Steinberg, I Elman, D Baron, EJ Modestino, ... Journal of systems and integrative neuroscience 4 (1), 10.15761/JSIN. 1000191, 2018 | 39 | 2018 |
| A systematic, intensive statistical investigation of data from the comprehensive analysis of reported drugs (CARD) for compliance and illicit opioid abstinence in substance … K Blum, D Han, EJ Modestino, S Saunders, AK Roy III, W Jacobs, ... Substance use & misuse 53 (2), 220-229, 2018 | 38 | 2018 |
| The benefits of genetic addiction risk score (GARS™) testing in substance use disorder (SUD) K Blum, EJ Modestino, M Gondre-Lewis, EJ Chapman, J Neary, D Siwicki, ... International journal of genomics and data mining 2018 (1), 115, 2018 | 38 | 2018 |
| Reward deficiency syndrome: Attentional/arousal subtypes, limitations of current diagnostic nosology, and future research EJ Modestino, K Blum, M Oscar-Berman, MS Gold, DD Duane, ... Journal of reward deficiency syndrome 1 (1), 6, 2015 | 37 | 2015 |
| A novel precision approach to overcome the “addiction pandemic” by incorporating genetic addiction risk severity (GARS) and dopamine homeostasis restoration K Blum, S Kazmi, EJ Modestino, BW Downs, D Bagchi, D Baron, ... Journal of Personalized Medicine 11 (3), 212, 2021 | 36 | 2021 |
| Exploration of epigenetic state hyperdopaminergia (Surfeit) and genetic trait hypodopaminergia (Deficit) during adolescent brain development K Blum, A Bowirrat, MCG Lewis, TA Simpatico, M Ceccanti, B Steinberg, ... Current psychopharmacology 10 (3), 181-196, 2021 | 33 | 2021 |
| Promoting precision addiction management (PAM) to combat the global opioid crisis K Blum, EJ Modestino, J Neary, MC Gondré-Lewis, D Siwicki, M Moran, ... Biomedical journal of scientific & technical research 2 (2), 1, 2018 | 32 | 2018 |
| Putative COVID-19 induction of reward deficiency syndrome (RDS) and associated behavioral addictions with potential concomitant dopamine depletion: is COVID-19 social … K Blum, JL Cadet, D Baron, RD Badgaiyan, R Brewer, EJ Modestino, ... Substance Use & Misuse 55 (14), 2438-2442, 2020 | 30 | 2020 |
David BaronProfessor USC psychiatryVerified email at usc.edu
